
Maryam Lustberg/LinkedIn
Jan 21, 2025, 16:40
Maryam Lustberg: More studies are necessary to define the implications of clonal hematopoiesis in breast cancer
Maryam Lustberg, Director of Breast Center/Chief Breast Oncology at Yale University School of Medicine, shared a post on LinkedIn about a recent paper by Christina Mayerhofer et al. published in Journal of Clinical Oncology:
“More studies are necessary to further define the implications of clonal hematopoiesis in patients with breast cancer and guide clinical decision making.”
“Clonal Hematopoiesis in Women With Breast Cancer”
Authors: Christina Mayerhofer, Rachel Freedman, Heather Parsons, Ann Partridge, Peter Miller.
More posts featuring Maryam Lustberg.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20